Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/2005

01-07-2005

The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer

Authors: Hiromasa Takahashi, Kenichi Watanabe, Masato Takahashi, Kazunori Taguchi, Fumiaki Sasaki, Satoru Todo

Published in: Breast Cancer | Issue 3/2005

Login to get access
Metadata
Title
The impact of bilateral breast cancer on the prognosis of breast cancer: a comparative study with unilateral breast cancer
Authors
Hiromasa Takahashi
Kenichi Watanabe
Masato Takahashi
Kazunori Taguchi
Fumiaki Sasaki
Satoru Todo
Publication date
01-07-2005
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 3/2005
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.2325/jbcs.12.196

Other articles of this Issue 3/2005

Breast Cancer 3/2005 Go to the issue

OriginalPaper

Prediction of early and late recurrence in patients with breast carcinoma

OriginalPaper

Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer

Report

A case of burkitt’s lymphoma involving both breasts

OriginalPaper

Probability of axillary lymph node metastasis when sentinel lymph node biopsy is negative in women with clinically node negative breast cancer: a bayesian approach

Report

Huge cavernous hemangioma arising in a male breast

Report

Two cases with long-term disease-free survival after resection and radiotherapy for solitary brain metastasis from breast cancer with extensive nodal metastases
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits